PNC FINANCIAL SERVICES GROUP, INC. - CONATUS PHARMACEUTICALS INC ownership

CONATUS PHARMACEUTICALS INC's ticker is CNAT and the CUSIP is 20600T108. A total of 55 filers reported holding CONATUS PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 0.48 and the average weighting 0.1%.

Quarter-by-quarter ownership
PNC FINANCIAL SERVICES GROUP, INC. ownership history of CONATUS PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2020$5,000
-16.7%
14,6190.0%0.00%
Q4 2019$6,000
-93.1%
14,619
-2.5%
0.00%
Q3 2018$87,000
+4250.0%
15,000
+1400.0%
0.00%
Q1 2016$2,000
-33.3%
1,0000.0%0.00%
Q4 2015$3,000
-25.0%
1,0000.0%0.00%
Q3 2015$4,0001,0000.00%
Other shareholders
CONATUS PHARMACEUTICALS INC shareholders Q4 2018
NameSharesValueWeighting ↓
MPM ASSET MANAGEMENT LLC 2,464,807$14,468,0005.57%
COURAGE CAPITAL MANAGEMENT LLC 192,486$1,130,0000.86%
ESSEX INVESTMENT MANAGEMENT CO LLC 90,455$531,0000.07%
Alambic Investment Management, L.P. 86,204$506,0000.07%
Kalos Management, Inc. 30,000$164,0000.05%
Dynamic Technology Lab Private Ltd 32,394$190,0000.03%
ELLINGTON MANAGEMENT GROUP LLC 60,600$356,0000.03%
PRELUDE CAPITAL MANAGEMENT, LLC 55,008$323,0000.02%
REILLY FINANCIAL ADVISORS, LLC 22,011$129,0000.02%
ACADIAN ASSET MANAGEMENT LLC 580,972$3,411,0000.02%
View complete list of CONATUS PHARMACEUTICALS INC shareholders